Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Dmitry Rykunov is a cancer researcher whose work bridges urologic oncology and tumor biology, with a particular focus on prostate cancer. His key research areas include the tumor microenvironment, inflammation-driven carcinogenesis, and the molecular underpinnings of aggressive disease. Dr. Rykunov’s major contribution is his pioneering study on the association between incidental pelvic inflammation and aggressive prostate cancer, which was the first to systematically examine how localized inflammatory processes may influence prostate cancer biology and clinical outcomes. This work, published in 2022 and already garnering 15 citations, has opened a new avenue for understanding how non-malignant conditions can shape tumor aggressiveness. By analyzing radical prostatectomy specimens, he demonstrated that pelvic inflammation is linked to a more aggressive phenotype, offering potential biomarkers for risk stratification. His findings have implications for both surgical pathology and personalized treatment planning. Dr. Rykunov’s research is notable for its translational impact, directly connecting histopathological observations to clinical decision-making. As his citation record grows, he is establishing himself as a rising voice in the study of inflammation’s role in cancer progression.